Language Selection

Get healthy now with MedBeds!
Click here to book your session

Protect your whole family with Orgo-Life® Quantum MedBed Energy Technology® devices.

Advertising by Adpathway

         

 Advertising by Adpathway

Lysosomal Proteases Degrade Amyloid Precursor Protein and Accelerate Tau Breakdown in Laboratory Models

4 hours ago 13

PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY

Orgo-Life the new way to the future

  Advertising by Adpathway

However, full-length amyloid precursor protein contains up to seven hundred and seventy amino acids depending on alternative splicing isoforms, and intact molecules are frequently detected within post-mortem amyloid plaques. While the cell-surface signaling roles of this precursor protein have received considerable attention, its physiological catabolism inside acidic compartments such as lysosomes has remained poorly characterized despite longstanding observations that precursors and their derivatives accumulate within the endolysosomal trafficking network.

To establish the baseline subcellular distribution of endogenous precursor molecules, investigators led by Caroline Ackley, Aimee W. Kao, and colleagues profiled neural models using confocal microscopy and density-gradient fractionation. In cultured human SH-SY5Y neuroblastoma cells maintained in an undifferentiated state, quantitative colocalization demonstrated that over half of the endogenous precursor protein pool resided within lysosomal compartments marked by Lamp1 and Lamp2 proteins, exhibiting substantially less overlap with early endosome markers like EEA1 or mitochondrial markers such as ATP5A1. Following a ten-day terminal differentiation regimen with retinoic acid and brain-derived neurotrophic factor that guided these neuroblastoma cells into a neuron-like phenotype, nearly forty percent of the precursor protein continued to colocalize stably with lysosomal markers.

To confirm that these intracellular localization patterns reflected genuine physiological compartmentalization in living mammals, the investigators turned to a genetically engineered LysoTag mouse model. Following rapid dounce homogenization of freshly harvested cerebral cortex and cerebellar tissues, intact organelles were isolated using anti-HA conjugated magnetic affinity beads. Western blot analysis of the resulting immunoprecipitates demonstrated a strong, specific enrichment of full-length amyloid precursor protein within cortical and cerebellar neuronal lysosomes compared against whole-cell tissue homogenates and unbound flow-through controls, thereby providing direct in vivo evidence that the precursor protein is abundantly positioned within the degradative lysosomal machinery.

Having substantiated the physical presence of amyloid precursor protein inside lysosomes, the team investigated which specific lumenal enzymes could degrade the large extracellular and lumenal fragment designated as soluble amyloid precursor protein. Using in vitro digestion assays resolved by silver-stained polyacrylamide gel electrophoresis across a physiological pH spectrum spanning 3.4, 4.5, 5.5, and neutral 7.4, the authors systematically evaluated fifteen recombinant enzymes, comprising fourteen cathepsins and asparagine endopeptidase. Most cysteine cathepsins digested the soluble precursor, although their catalytic efficiencies varied markedly according to ambient acidity. Notably, cathepsin H cleaved the precursor at pH 4.5 despite lacking activity toward alpha-synuclein, tau, or TDP-43 under identical conditions in previous studies. Similarly, cathepsin V degraded the soluble precursor across pH 3.4, 4.5, and 5.5, contrasting with its narrow activity restricted strictly to pH 3.4 on alternative neurodegenerative substrates. Serine proteases also cleaved the precursor, with cathepsin G demonstrating proteolysis from pH 4.5 through 7.4, while aspartyl proteases D and E cleaved efficiently under acidic conditions.

To obtain single-amino-acid resolution of these enzymatic cleavages, the researchers utilized multiplexed substrate profiling by mass spectrometry. They generated an overlapping peptide library consisting of eighteen-amino-acid fragments spanning the entire 770-residue sequence of human precursor protein, substituting all native cysteine residues with alanines to circumvent artefactual disulfide cross-linking and appending solubilizing terminal residues for liquid chromatography-tandem mass spectrometry. Incubating this synthetic library with thirteen individual lysosomal enzymes across multiple reaction times and pH points identified 390 unique cleavage sites across the full precursor protein sequence.

Mapping these cleavage positions along the primary sequence revealed a non-uniform distribution characterized by distinct proteolytic hot spots and quiet zones. Redundant cleavage sites that could be cleaved by multiple distinct proteases clustered heavily within the amino-terminal E1 domain, the Kunitz protease inhibitor domain, and the acidic E2 domain. Conversely, the flexible structural linker connecting the E1 and Kunitz domains proved remarkably resistant to enzymatic digestion. Strikingly, half of all identified scissile bonds—specifically 195 of the 390 sites—were non-redundant cut sites recognized by only a single lysosomal enzyme. Cathepsin G accounted for the largest individual share of these unique cleavages, generating fifty-eight non-redundant cuts representing twenty-nine point seven percent of the single-protease sites, which was almost double the number produced by the next most selective enzyme, asparagine endopeptidase. Correlation plots further indicated that while cathepsins S, L, E, and K shared substantial functional overlap, enzymes like cathepsin B exhibited weak or negative correlation with other proteases.

Because lysosomes in aging and diseased cells often undergo progressive lumenal alkalinization, the study evaluated how shifting pH altered cathepsin catalytic specificity and substrate cleavage repertoires. Consensus sequence motifs generated through probability-based iceLogo visualizations aligned with recognized MEROPS database entries for most cysteine and aspartyl enzymes, while defining previously unannotated preferences for serine proteases, revealing non-polar preferences across P3 to P3 prime for cathepsin A and aromatic bulky residue preferences for cathepsin G. Crucially, elevating pH by a single unit from 4.5 to 5.5 severely curtailed peptide cleavage across multiple key enzymes. Asparagine endopeptidase experienced a contraction from one hundred and two cleavage sites down to sixty-six sites, while cathepsin L suffered an eighty-four percent reduction, dropping from one hundred and seventy-three scissile sites at pH 4.5 down to only forty-five at pH 5.5. Because many of these sensitive positions reside within the amyloid-beta core, loss of lysosomal acidity substantially impedes the normal clearing of precursor fragments.

The researchers next examined whether familial Alzheimer’s disease point mutations located within the amyloid-beta sequence alter susceptibility to lysosomal proteolysis independently of secretase processing. Unlike the Swedish mutation that elevates beta-secretase cleavage or the London mutation that alters gamma-secretase ratios, the Arctic E693G and Dutch E693Q mutations localize far from secretase recognition junctions and present clinically with low parenchymal amyloid plaque burden on positron emission tomography despite severe pathology. Observing that ten lysosomal proteases target residues near position 693, the team synthesized fluorogenic octapeptides flanking this locus and monitored real-time cleavage velocity. Wild-type substrates experienced slow or modest proteolysis, whereas both the Arctic and Dutch variant peptides were rapidly cleaved by cathepsins B, G, K, L, S, and V. Not a single tested protease exhibited decreased activity against the mutant sequences relative to wild type, indicating that these substitutions accelerate interior cleavage within the amyloid-beta peptide sequence.

To validate whether enhanced mutant catabolism operated inside whole cells, the authors engineered stable, doxycycline-inducible SH-SY5Y cell lines expressing FLAG-tagged full-length wild-type, Arctic, or Dutch precursor proteins. Following retinoic acid and BDNF differentiation into a mature neuronal state, transgene expression was induced and intracellular protein abundance was monitored across five days by quantitative Western blotting normalized against GAPDH loading controls. Over the five-day incubation, levels of precursor protein harboring the Arctic or Dutch mutations declined by approximately forty percent, compared to an average clearance reduction of twenty-five percent observed for the wild-type reference protein. The investigators noted that this steady-state clearance difference, while less dramatic than the logarithmic kinetic accelerations measured using isolated peptides in vitro, directly reflected the cumulative degradative burden executed across the complete complement of cellular lysosomal proteases.

In evaluating broader functional interactions among degradative cascades, the investigators tested whether soluble amyloid precursor protein, known to inhibit serine proteases like trypsin and thrombin via its Kunitz protease inhibitor domain, might suppress lysosomal serine proteases. While the soluble precursor inhibited trypsin in a dose-dependent manner as anticipated, it produced the opposite effect when combined with cathepsin G. In biochemical fluorogenic assays utilizing a synthetic tau peptide spanning residues 274 to 282 containing a scissile bond at residue 280, the presence of soluble precursor protein dramatically accelerated cathepsin G proteolytic cleavage rather than impeding it. Furthermore, adding soluble precursor protein accelerated the digestion of full-length FITC-conjugated recombinant human tau-441, as well as full-length unlabeled tau protein.

This catalytic enhancement exhibited striking biochemical specificity: soluble precursor protein failed to alter cathepsin G cleavage of a non-specific casein substrate, and substituting cathepsin G with the cysteine protease cathepsin L abolished the accelerative phenomenon. The authors suggested that soluble precursor protein might function analogously to known lysosomal cofactors, such as progranulin assisting cathepsin D or saposin C stimulating glucocerebrosidase, potentially through allosteric modulation or the assembly of a ternary degradation complex.

Subject of Research: Lysosomal protease-mediated degradation of amyloid precursor protein and regulation of tau proteolysis

Article Title: Lysosomal protease-mediated APP degradation is pH-dependent, mutation-sensitive, and facilitates tau proteolysis

Article References: Ackley, C., Liau, Z., Arya, S., Antee, T., Cheang, E., Knudsen, G. M., Lane-Donovan, C., Sampognaro, P. J., & Kao, A. W. (2026). Lysosomal protease-mediated APP degradation is pH-dependent, mutation-sensitive, and facilitates tau proteolysis. Molecular Neurodegeneration Advances, 2(1), Article 10. https://doi.org/10.1186/s44477-025-00017-6

Image Credits: AI Generated

DOI: 10.1186/s44477-025-00017-6

Keywords: Amyloid precursor protein, Lysosomal proteases, Cathepsins, Tau proteolysis, Cathepsin G, Cathepsin L, Multiplexed substrate profiling, Mass spectrometry, Arctic mutation, Dutch mutation, Endolysosomal system, Lysosomal pH, Kunitz protease inhibitor domain, SH-SY5Y neuroblastoma, LysoTag mice, Alzheimer's disease pathology, Asparagine endopeptidase, Protease Nexin II

Read Entire Article

         

        

Start the new Vibrations with a Medbed Franchise today!  

Protect your whole family with Quantum Orgo-Life® devices

  Advertising by Adpathway